World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
24823
World Ranking
4981
National Ranking
2393

Overview

David F. Stroncek is affiliated with the National Institutes of Health in the United States and has contributed extensively to the fields of medicine, biochemistry, genetics, and molecular biology. Their research primarily focuses on oncology, genetics, immunology, molecular biology, and hematology, with a significant emphasis on CAR-T cell therapy research.

Their most cited recent papers include:

  • CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial (2020), Journal of Clinical Oncology
  • Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL (2021), Journal of Clinical Oncology
  • Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma (2020), Nature Medicine
  • TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers (2021), Nature Medicine
  • Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells (2021), Blood

The researcher has published frequently in the following venues:

  • Blood (17 publications)
  • Cytotherapy (16 publications)
  • Journal of Translational Medicine (10 publications)
  • Transplantation and Cellular Therapy (8 publications)
  • Transfusion (6 publications)

Frequent co-authors collaborating with David F. Stroncek include:

  • Steven L. Highfill (61 publications)
  • Sandhya R. Panch (34 publications)
  • Ping Jin (30 publications)
  • Nirali N. Shah (28 publications)
  • Lipei Shao (28 publications)

The main topics of their work encompass:

  • CAR-T cell therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • Hematopoietic Stem Cell Transplantation
  • Mesenchymal stem cell research
  • Immunotherapy and Immune Responses

David F. Stroncek's work connects molecular biology and immunotherapy through an examination of immune cell functions and genetic mechanisms underlying therapeutic approaches, particularly CAR-T therapies. Their research spans fundamental and translational studies targeting hematological malignancies and viral-related cancers.

Best Publications

  • CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.

    Terry J Fry;Nirali N Shah;Rimas J Orentas;Maryalice Stetler-Stevenson

  • Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program

    Nancy A. Kernan;Glenn Bartsch;Robert C. Ash;Patrick G. Beatty

  • T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

    Syed Abbas Ali;Victoria Shi;Irina Maric;Michael Wang

  • T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

    Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  • NAFLD causes selective CD4 + T lymphocyte loss and promotes hepatocarcinogenesis

    Chi Ma;Aparna H. Kesarwala;Tobias Eggert;José Medina-Echeverz

  • The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective study

    Christopher C. Silliman;Andrew J. Paterson;William O. Dickey;David F. Stroncek

  • International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

    Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  • Complement activation and neutropenia occurring during cardiopulmonary bypass

    Dale E. Hammerschmidt;David F. Stroncek;Timothy K. Bowers;Carol J. Lammi-Keefe

  • Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies.

    Marianna Sabatino;Jinhui Hu;Michele Sommariva;Michele Sommariva;Sanjivan Gautam

  • Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL.

    Nirali N Shah;Daniel W Lee;Bonnie Yates;Constance M Yuan

  • Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models

    Wolfram Goessling;Robyn S. Allen;Xiao Guan;Ping Jin

  • Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.

    D F Stroncek;M E Clay;M L Petzoldt;J Smith

  • Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

    Jennifer N Brudno;Norris Lam;Danielle Vanasse;Yueh-Wei Shen

  • Allogeneic blood stem cell transplantation: considerations for donors

    Paolo Anderlini;Martin Körbling;David Dale;Alois Gratwohl

  • MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells.

    Jiaqiang Ren;Ping Jin;Ena Wang;Francesco M Marincola

  • Future perspectives in melanoma research

    Paolo A. Ascierto;Sanjiv Agarwala;Gerardo Botti;Alessandra Cesano

  • Main roads to melanoma

    Giuseppe Palmieri;Mariaelena Capone;Maria Libera Ascierto;Giusy Gentilcore

  • Adverse reactions in patients transfused with cryopreserved marrow

    D. F. Stroncek;S. K. Fautsch;L. C. Lasky;D. D. Hurd

  • Characterization of a New Alloantigen (SH) on the Human Neutrophil Fcγreceptor IIIb

    Juergen Bux;Ernst-Ludwig Stein;Ernst-Ludwig Stein;Philippe Bierling;Philippe Bierling;Patricia Fromont;Patricia Fromont

  • Cell and gene therapies: moving from research to clinic

    David F Stroncek;Raj K Puri

Frequent Co-Authors

Francesco M. Marincola
Francesco M. Marincola National Institutes of Health
Jeffrey McCullough
Jeffrey McCullough University of Minnesota
Susan F. Leitman
Susan F. Leitman National Institutes of Health
Crystal L. Mackall
Crystal L. Mackall Stanford University
Terry J. Fry
Terry J. Fry University of Colorado Denver
Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Ena Wang
Ena Wang Toro bio
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
John F. Tisdale
John F. Tisdale National Institutes of Health
Maryalice Stetler-Stevenson
Maryalice Stetler-Stevenson National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re passionate about Biology or Biochemistry, numerous online programs can help you translate your interests into a rewarding career in healthcare or allied sciences. Students looking for hands-on patient care careers often explore options like ultrasound tech school online, which prepares you for a fast-growing specialty using advanced imaging technology.

Those interested in diagnostics may prefer rad tech online programs, which focus on radiography and X-ray procedures. For students aiming to combine biology with nutrition, top dietetics masters programs offer advanced training in diet planning, health promotion, and lifestyle management.

Entry-level healthcare positions can also be attained via online programs. Many choose to start their journey with online medical assistant programs fafsa approved—a practical, affordable pathway with financial aid options.

Each of these online degrees provides a strong foundation for diverse career pathways and enables you to study flexibly while preparing for essential roles across the healthcare industry.

Best Scientists Citing David F. Stroncek

Trending Scientists